-
1
-
-
0003074343
-
Experimental studies on the pathogenesis of contact eczema in the guinea-pig
-
1:STN:280:DyaG1c%2Fls1Sitg%3D%3D 13513182
-
Frey JR, Wenk P. Experimental studies on the pathogenesis of contact eczema in the guinea-pig. Int Arch Allergy Appl Immunol. 1957;11:81-100.
-
(1957)
Int Arch Allergy Appl Immunol
, vol.11
, pp. 81-100
-
-
Frey, J.R.1
Wenk, P.2
-
2
-
-
66249140545
-
Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity
-
2680335 19468301
-
Greter M, Hofmann J, Becher B. Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol. 2009;7:e1000109.
-
(2009)
PLoS Biol
, vol.7
-
-
Greter, M.1
Hofmann, J.2
Becher, B.3
-
3
-
-
0030906253
-
On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice
-
2196355 1:CAS:528:DyaK2sXktVektLo%3D 9182687
-
Karrer U, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, Miyawaki S, et al. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med. 1997;185:2157-70.
-
(1997)
J Exp Med
, vol.185
, pp. 2157-2170
-
-
Karrer, U.1
Althage, A.2
Odermatt, B.3
Roberts, C.W.4
Korsmeyer, S.J.5
Miyawaki, S.6
Hengartner, H.7
Zinkernagel, R.M.8
-
4
-
-
0029030393
-
Fibroblasts as efficient antigen-presenting cells in lymphoid organs
-
1:STN:280:DyaK2M3ot1Siuw%3D%3D 7761853
-
Kundig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M, Lother H, et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 1995;268:1343-7.
-
(1995)
Science
, vol.268
, pp. 1343-1347
-
-
Kundig, T.M.1
Bachmann, M.F.2
DiPaolo, C.3
Simard, J.J.4
Battegay, M.5
Lother, H.6
Gessner, A.7
Kuhlcke, K.8
Ohashi, P.S.9
Hengartner, H.10
-
5
-
-
0030975532
-
Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity
-
1:CAS:528:DyaK2sXjsF2gtrs%3D 9176709
-
Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev. 1997;156:199-209.
-
(1997)
Immunol Rev
, vol.156
, pp. 199-209
-
-
Zinkernagel, R.M.1
Ehl, S.2
Aichele, P.3
Oehen, S.4
Kundig, T.5
Hengartner, H.6
-
6
-
-
0034210006
-
Localization dose and time of antigens determine immune reactivity
-
1:CAS:528:DC%2BD3cXltVCitL8%3D 10910735 discussion 257-344
-
Zinkernagel RM. Localization dose and time of antigens determine immune reactivity. Semin Immunol. 2000;12:163-71. discussion 257-344.
-
(2000)
Semin Immunol
, vol.12
, pp. 163-171
-
-
Zinkernagel, R.M.1
-
7
-
-
47049100427
-
Nanoparticles target distinct dendritic cell populations according to their size
-
1:CAS:528:DC%2BD1cXmsVGrsL0%3D 18389478
-
Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol. 2008;38:1404-13.
-
(2008)
Eur J Immunol
, vol.38
, pp. 1404-1413
-
-
Manolova, V.1
Flace, A.2
Bauer, M.3
Schwarz, K.4
Saudan, P.5
Bachmann, M.F.6
-
8
-
-
0017582656
-
Intralymphatic immunization: current status
-
1:STN:280:DyaE2s3gsVKksw%3D%3D 872860
-
Juillard GJ, Boyer PJ. Intralymphatic immunization: current status. Eur J Cancer. 1977;13:439-40.
-
(1977)
Eur J Cancer
, vol.13
, pp. 439-440
-
-
Juillard, G.J.1
Boyer, P.J.2
-
9
-
-
0020644713
-
Production of antibodies by inoculation into lymph nodes
-
1:CAS:528:DyaL3sXltVehu78%3D 6346012
-
Sigel MB, Sinha YN, VanderLaan WP. Production of antibodies by inoculation into lymph nodes. Methods Enzymol. 1983;93:3-12.
-
(1983)
Methods Enzymol
, vol.93
, pp. 3-12
-
-
Sigel, M.B.1
Sinha, Y.N.2
VanderLaan, W.P.3
-
10
-
-
0023182294
-
Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips
-
1:CAS:528:DyaL2sXkvFCrsb8%3D 3571992
-
Nilsson BO, Svalander PC, Larsson A. Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips. J Immunol Methods. 1987;99:67-75.
-
(1987)
J Immunol Methods
, vol.99
, pp. 67-75
-
-
Nilsson, B.O.1
Svalander, P.C.2
Larsson, A.3
-
11
-
-
84872616132
-
Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis
-
1:CAS:528:DC%2BC3sXos1Wkug%3D%3D 23273509
-
Waeckerle-Men Y, Bruffaerts N, Liang Y, Jurion F, Sander P, Kundig TM, et al. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis. Vaccine. 2013;31:1057-64.
-
(2013)
Vaccine
, vol.31
, pp. 1057-1064
-
-
Waeckerle-Men, Y.1
Bruffaerts, N.2
Liang, Y.3
Jurion, F.4
Sander, P.5
Kundig, T.M.6
Huygen, K.7
Johansen, P.8
-
12
-
-
33846220252
-
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients
-
1:CAS:528:DC%2BD28XhtlCrtr%2FL 17189411
-
Lesimple T, Neidhard EM, Vignard V, Lefeuvre C, Adamski H, Labarriere N, et al. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients. Clin Cancer Res. 2006;12:7380-8.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7380-7388
-
-
Lesimple, T.1
Neidhard, E.M.2
Vignard, V.3
Lefeuvre, C.4
Adamski, H.5
Labarriere, N.6
Carsin, A.7
Monnier, D.8
Collet, B.9
Clapisson, G.10
-
13
-
-
0032996260
-
Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells
-
1:STN:280:DyaK1MzktFCitw%3D%3D 10414465
-
Mackensen A, Krause T, Blum U, Uhrmeister P, Mertelsmann R, Lindemann A. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol Immunother. 1999;48:118-22.
-
(1999)
Cancer Immunol Immunother
, vol.48
, pp. 118-122
-
-
Mackensen, A.1
Krause, T.2
Blum, U.3
Uhrmeister, P.4
Mertelsmann, R.5
Lindemann, A.6
-
14
-
-
33750326077
-
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes
-
2174601 1:CAS:528:DC%2BD28XhtVartbjO 17020987
-
Grover A, Kim GJ, Lizee G, Tschoi M, Wang G, Wunderlich JR, et al. Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes. Clin Cancer Res. 2006;12:5801-8.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5801-5808
-
-
Grover, A.1
Kim, G.J.2
Lizee, G.3
Tschoi, M.4
Wang, G.5
Wunderlich, J.R.6
Rosenberg, S.A.7
Hwang, S.T.8
Hwu, P.9
-
15
-
-
0347627711
-
Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys
-
1:CAS:528:DC%2BD3sXpsV2rur8%3D 14662894
-
Brown K, Gao W, Alber S, Trichel A, Murphey-Corb M, Watkins SC, et al. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys. J Immunol. 2003;171:6875-82.
-
(2003)
J Immunol
, vol.171
, pp. 6875-6882
-
-
Brown, K.1
Gao, W.2
Alber, S.3
Trichel, A.4
Murphey-Corb, M.5
Watkins, S.C.6
Gambotto, A.7
Barratt-Boyes, S.M.8
-
16
-
-
27944504770
-
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
-
16258544
-
de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005;23:1407-13.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1407-1413
-
-
De Vries, I.J.1
Lesterhuis, W.J.2
Barentsz, J.O.3
Verdijk, P.4
Van Krieken, J.H.5
Boerman, O.C.6
Oyen, W.J.7
Bonenkamp, J.J.8
Boezeman, J.B.9
Adema, G.J.10
-
17
-
-
0037226599
-
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state
-
12517769
-
De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003;63:12-7.
-
(2003)
Cancer Res
, vol.63
, pp. 12-17
-
-
De Vries, I.J.1
Krooshoop, D.J.2
Scharenborg, N.M.3
Lesterhuis, W.J.4
Diepstra, J.H.5
Van Muijen, G.N.6
Strijk, S.P.7
Ruers, T.J.8
Boerman, O.C.9
Oyen, W.J.10
-
18
-
-
0037899037
-
Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects
-
1:CAS:528:DC%2BD3sXkvFynu74%3D 12690521
-
Lesimple T, Moisan A, Carsin A, Ollivier I, Mousseau M, Meunier B, et al. Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects. Cancer Immunol Immunother. 2003;52:438-44.
-
(2003)
Cancer Immunol Immunother
, vol.52
, pp. 438-444
-
-
Lesimple, T.1
Moisan, A.2
Carsin, A.3
Ollivier, I.4
Mousseau, M.5
Meunier, B.6
Leberre, C.7
Collet, B.8
Quillien, V.9
Drenou, B.10
-
19
-
-
34147160202
-
Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques
-
1:CAS:528:DC%2BD2sXkvFykt7w%3D 17385685
-
Koopman G, Bogers WM, van Gils M, Koornstra W, Barnett S, Morein B, et al. Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques. J Med Virol. 2007;79:474-82.
-
(2007)
J Med Virol
, vol.79
, pp. 474-482
-
-
Koopman, G.1
Bogers, W.M.2
Van Gils, M.3
Koornstra, W.4
Barnett, S.5
Morein, B.6
Lehner, T.7
Heeney, J.L.8
-
20
-
-
20044366365
-
Direct intralymphatic injection of peptide vaccines enhances immunogenicity
-
1:CAS:528:DC%2BD2MXhvFKls7k%3D 15682446
-
Johansen P, Haffner AC, Koch F, Zepter K, Erdmann I, Maloy K, et al. Direct intralymphatic injection of peptide vaccines enhances immunogenicity. Eur J Immunol. 2005;35:568-74.
-
(2005)
Eur J Immunol
, vol.35
, pp. 568-574
-
-
Johansen, P.1
Haffner, A.C.2
Koch, F.3
Zepter, K.4
Erdmann, I.5
Maloy, K.6
Simard, J.J.7
Storni, T.8
Senti, G.9
Bot, A.10
-
21
-
-
63449140410
-
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides
-
1:CAS:528:DC%2BD1MXktFSktbs%3D 19428867
-
Smith KA, Tam VL, Wong RM, Pagarigan RR, Meisenburg BL, Joea DK, et al. Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine. 2009;27:2603-15.
-
(2009)
Vaccine
, vol.27
, pp. 2603-2615
-
-
Smith, K.A.1
Tam, V.L.2
Wong, R.M.3
Pagarigan, R.R.4
Meisenburg, B.L.5
Joea, D.K.6
Liu, X.7
Sanders, C.8
Diamond, D.9
Kundig, T.M.10
-
22
-
-
0035853103
-
Intralymphatic immunization enhances DNA vaccination
-
30648 1:CAS:528:DC%2BD3MXit1alsbc%3D 11248073
-
Maloy KJ, Erdmann I, Basch V, Sierro S, Kramps TA, Zinkernagel RM, et al. Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci U S A. 2001;98:3299-303.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 3299-3303
-
-
Maloy, K.J.1
Erdmann, I.2
Basch, V.3
Sierro, S.4
Kramps, T.A.5
Zinkernagel, R.M.6
Oehen, S.7
Kundig, T.M.8
-
23
-
-
32344451450
-
Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responses
-
1:CAS:528:DC%2BD28Xhs1Smtrc%3D 16225968
-
Heinzerling L, Basch V, Maloy K, Johansen P, Senti G, Wuthrich B, et al. Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responses. Vaccine. 2006;24:1389-94.
-
(2006)
Vaccine
, vol.24
, pp. 1389-1394
-
-
Heinzerling, L.1
Basch, V.2
Maloy, K.3
Johansen, P.4
Senti, G.5
Wuthrich, B.6
Storni, T.7
Kundig, T.M.8
-
24
-
-
44949242538
-
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma
-
1:CAS:528:DC%2BD1cXjt1Cisr8%3D 18481391
-
Weber J, Boswell W, Smith J, Hersh E, Snively J, Diaz M, et al. Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma. J Immunother. 2008;31:215-23.
-
(2008)
J Immunother
, vol.31
, pp. 215-223
-
-
Weber, J.1
Boswell, W.2
Smith, J.3
Hersh, E.4
Snively, J.5
Diaz, M.6
Miles, S.7
Liu, X.8
Obrocea, M.9
Qiu, Z.10
Bot, A.11
-
25
-
-
0037664871
-
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
-
1:CAS:528:DC%2BD3sXlslagur0%3D 12833467
-
Tagawa ST, Lee P, Snively J, Boswell W, Ounpraseuth S, Lee S, et al. Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma. Cancer. 2003;98:144-54.
-
(2003)
Cancer
, vol.98
, pp. 144-154
-
-
Tagawa, S.T.1
Lee, P.2
Snively, J.3
Boswell, W.4
Ounpraseuth, S.5
Lee, S.6
Hickingbottom, B.7
Smith, J.8
Johnson, D.9
Weber, J.S.10
-
26
-
-
80051550377
-
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors
-
Weber JS, Vogelzang NJ, Ernstoff MS, Goodman OB, Cranmer LD, Marshall JL, et al. A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. J Immunother. 2011;34:556-67.
-
(2011)
J Immunother
, vol.34
, pp. 556-567
-
-
Weber, J.S.1
Vogelzang, N.J.2
Ernstoff, M.S.3
Goodman, O.B.4
Cranmer, L.D.5
Marshall, J.L.6
-
27
-
-
79955489170
-
Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial
-
Ribas A, Weber JS, Chmielowski B, Comin-Anduix B, Lu D, Douek M, et al. Intra-lymph node prime-boost vaccination against Melan A and tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial. Clin Cancer Res. 2011;17:2987-96.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2987-2996
-
-
Ribas, A.1
Weber, J.S.2
Chmielowski, B.3
Comin-Anduix, B.4
Lu, D.5
Douek, M.6
-
28
-
-
15844394511
-
Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
-
1:CAS:528:DyaK28XjvF2isr8%3D 8673922
-
Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med. 1996;2:767-75.
-
(1996)
Nat Med
, vol.2
, pp. 767-775
-
-
Lehner, T.1
Wang, Y.2
Cranage, M.3
Bergmeier, L.A.4
Mitchell, E.5
Tao, L.6
Hall, G.7
Dennis, M.8
Cook, N.9
Brookes, R.10
-
29
-
-
0031985655
-
Induction of Th2 cytokine expression for p27-specific IgA B-cell responses after targeted lymph node immunization with simian immunodeficiency virus in rhesus macaques
-
1:CAS:528:DyaK1cXjs1yguw%3D%3D 9419166
-
Kawabata S, Miller CJ, Lehner T, Fujihashi K, Kubota M, McGhee JR, et al. Induction of Th2 cytokine expression for p27-specific IgA B-cell responses after targeted lymph node immunization with simian immunodeficiency virus in rhesus macaques. J Infect Dis. 1998;177:26-33.
-
(1998)
J Infect Dis
, vol.177
, pp. 26-33
-
-
Kawabata, S.1
Miller, C.J.2
Lehner, T.3
Fujihashi, K.4
Kubota, M.5
McGhee, J.R.6
Imaoka, K.7
Hioi, T.8
Kiyono, H.9
-
30
-
-
0033624681
-
The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection
-
1:CAS:528:DC%2BD3cXlvFenu74%3D 10940916
-
Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M, et al. The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol. 2000;30:2245-56.
-
(2000)
Eur J Immunol
, vol.30
, pp. 2245-2256
-
-
Lehner, T.1
Mitchell, E.2
Bergmeier, L.3
Singh, M.4
Spallek, R.5
Cranage, M.6
Hall, G.7
Dennis, M.8
Villinger, F.9
Wang, Y.10
-
31
-
-
12144290783
-
A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection
-
15090826
-
Bogers WM, Bergmeier LA, Ma J, Oostermeijer H, Wang Y, Kelly CG, et al. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. Aids. 2004;18:25-36.
-
(2004)
Aids
, vol.18
, pp. 25-36
-
-
Bogers, W.M.1
Bergmeier, L.A.2
Ma, J.3
Oostermeijer, H.4
Wang, Y.5
Kelly, C.G.6
Ten Haaft, P.7
Singh, M.8
Heeney, J.L.9
Lehner, T.10
-
32
-
-
3843071049
-
CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection
-
1:CAS:528:DC%2BD2cXmsVCqsbY%3D 15356916
-
Bogers WM, Bergmeier LA, Oostermeijer H, ten Haaft P, Wang Y, Kelly CG, et al. CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection. Vaccine. 2004;22:2974-84.
-
(2004)
Vaccine
, vol.22
, pp. 2974-2984
-
-
Bogers, W.M.1
Bergmeier, L.A.2
Oostermeijer, H.3
Ten Haaft, P.4
Wang, Y.5
Kelly, C.G.6
Singh, M.7
Heeney, J.L.8
Lehner, T.9
-
33
-
-
0030587188
-
Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes
-
1:CAS:528:DyaK28Xls1aisbs%3D 8805653
-
Klavinskis LS, Bergmeier LA, Gao L, Mitchell E, Ward RG, Layton G, et al. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J Immunol. 1996;157:2521-7.
-
(1996)
J Immunol
, vol.157
, pp. 2521-2527
-
-
Klavinskis, L.S.1
Bergmeier, L.A.2
Gao, L.3
Mitchell, E.4
Ward, R.G.5
Layton, G.6
Brookes, R.7
Meyers, N.J.8
Lehner, T.9
-
34
-
-
0028064272
-
Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates
-
1:CAS:528:DyaK2cXlslOis7g%3D 7519218
-
Lehner T, Bergmeier LA, Tao L, Panagiotidi C, Klavinskis LS, Hussain L, et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J Immunol. 1994;153:1858-68.
-
(1994)
J Immunol
, vol.153
, pp. 1858-1868
-
-
Lehner, T.1
Bergmeier, L.A.2
Tao, L.3
Panagiotidi, C.4
Klavinskis, L.S.5
Hussain, L.6
Ward, R.G.7
Meyers, N.8
Adams, S.E.9
Gearing, A.J.10
-
35
-
-
0028525862
-
Effect of Whole Staphylococcus aureus and Mode of Immunization on Bovine Opsonizing Antibodies to Capsule
-
1:CAS:528:DyaK2cXmsFent7Y%3D 7836584
-
Guidry AJ, O'Brian CN, Oliver SP, Dowlen HH, Douglass LW. Effect of Whole Staphylococcus aureus and Mode of Immunization on Bovine Opsonizing Antibodies to Capsule. J Dairy Sci. 1994;77:2965-74.
-
(1994)
J Dairy Sci
, vol.77
, pp. 2965-2974
-
-
Guidry, A.J.1
O'Brian, C.N.2
Oliver, S.P.3
Dowlen, H.H.4
Douglass, L.W.5
-
36
-
-
0035963379
-
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
-
1:CAS:528:DC%2BD3MXltVCru70%3D 11429607
-
Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 2001;411:1058-64.
-
(2001)
Nature
, vol.411
, pp. 1058-1064
-
-
Ochsenbein, A.F.1
Sierro, S.2
Odermatt, B.3
Pericin, M.4
Karrer, U.5
Hermans, J.6
Hemmi, S.7
Hengartner, H.8
Zinkernagel, R.M.9
-
37
-
-
0018361540
-
Distribution and consequences of cell suspensions following intralymphatic infusion
-
1:STN:280:DyaL3c%2FitFGgug%3D%3D 486731
-
Juillard GJ, Boyer PJ, Niewisch H, Hom M. Distribution and consequences of cell suspensions following intralymphatic infusion. Bull Cancer. 1979;66:217-28.
-
(1979)
Bull Cancer
, vol.66
, pp. 217-228
-
-
Juillard, G.J.1
Boyer, P.J.2
Niewisch, H.3
Hom, M.4
-
38
-
-
0017067260
-
Intralymphatic infusion of autochthonous tumor cells in canine lymphoma
-
1:STN:280:DyaE2s%2FgsFyksA%3D%3D 972110
-
Juillard GJ, Boyer PJ, Snow HD. Intralymphatic infusion of autochthonous tumor cells in canine lymphoma. Int J Radiat Oncol Biol Phys. 1976;1:497-503.
-
(1976)
Int J Radiat Oncol Biol Phys
, vol.1
, pp. 497-503
-
-
Juillard, G.J.1
Boyer, P.J.2
Snow, H.D.3
-
39
-
-
0018194647
-
A phase I study of active specific intralymphatic immunotherapy (ASILI)
-
1:STN:280:DyaE1c7ovVKnsA%3D%3D 77718
-
Juillard GJ, Boyer PJ, Yamashiro CH. A phase I study of active specific intralymphatic immunotherapy (ASILI). Cancer. 1978;41:2215-25.
-
(1978)
Cancer
, vol.41
, pp. 2215-2225
-
-
Juillard, G.J.1
Boyer, P.J.2
Yamashiro, C.H.3
-
40
-
-
0017364056
-
Regional intralymphatic infusion (ILI) of irradiated tumor cells with evidence of distant effects
-
1:STN:280:DyaE2s%2FovFaisw%3D%3D 832227
-
Juillard GJ, Boyer PJ, Yamashiro CH, Snow HD, Weisenburger TH, McCarthy T, et al. Regional intralymphatic infusion (ILI) of irradiated tumor cells with evidence of distant effects. Cancer. 1977;39:126-30.
-
(1977)
Cancer
, vol.39
, pp. 126-130
-
-
Juillard, G.J.1
Boyer, P.J.2
Yamashiro, C.H.3
Snow, H.D.4
Weisenburger, T.H.5
McCarthy, T.6
Miller, R.J.7
-
41
-
-
0035850952
-
Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus
-
1:STN:280:DC%2BD3Mrit1OitA%3D%3D 11567745
-
Finerty S, Stokes CR, Gruffydd-Jones TJ, Hillman TJ, Barr FJ, Harbour DA. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. Vaccine. 2001;20:49-58.
-
(2001)
Vaccine
, vol.20
, pp. 49-58
-
-
Finerty, S.1
Stokes, C.R.2
Gruffydd-Jones, T.J.3
Hillman, T.J.4
Barr, F.J.5
Harbour, D.A.6
-
42
-
-
20844455173
-
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration
-
von Beust BR, Johansen P, Smith KA, Bot A, Storni T, Kundig TM. Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur J Immunol. 2005;35:1869-76.
-
(2005)
Eur J Immunol
, vol.35
, pp. 1869-1876
-
-
Von Beust, B.R.1
Johansen, P.2
Smith, K.A.3
Bot, A.4
Storni, T.5
Kundig, T.M.6
-
43
-
-
1642566566
-
Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects
-
1:CAS:528:DC%2BD2cXptl2hsg%3D%3D 14734761
-
Storni T, Ruedl C, Schwarz K, Schwendener RA, Renner WA, Bachmann MF. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol. 2004;172:1777-85.
-
(2004)
J Immunol
, vol.172
, pp. 1777-1785
-
-
Storni, T.1
Ruedl, C.2
Schwarz, K.3
Schwendener, R.A.4
Renner, W.A.5
Bachmann, M.F.6
-
44
-
-
51549096629
-
Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity
-
1:CAS:528:DC%2BD1cXhtVSiu73F 18713969
-
Bourquin C, Anz D, Zwiorek K, Lanz AL, Fuchs S, Weigel S, et al. Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity. J Immunol. 2008;181:2990-8.
-
(2008)
J Immunol
, vol.181
, pp. 2990-2998
-
-
Bourquin, C.1
Anz, D.2
Zwiorek, K.3
Lanz, A.L.4
Fuchs, S.5
Weigel, S.6
Wurzenberger, C.7
Von Der Borch, P.8
Golic, M.9
Moder, S.10
-
45
-
-
63349086255
-
Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy
-
1:CAS:528:DC%2BD1MXpvFelsro%3D 19339803
-
Martinez-Gomez JM, Johansen P, Erdmann I, Senti G, Crameri R, Kundig TM. Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy. Int Arch Allergy Immunol. 2009;150:59-65.
-
(2009)
Int Arch Allergy Immunol
, vol.150
, pp. 59-65
-
-
Martinez-Gomez, J.M.1
Johansen, P.2
Erdmann, I.3
Senti, G.4
Crameri, R.5
Kundig, T.M.6
-
46
-
-
23244434086
-
Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey
-
16083793
-
Arbes Jr SJ, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116:377-83.
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 377-383
-
-
Arbes, S.J.1
Gergen, P.J.2
Elliott, L.3
Zeldin, D.C.4
-
47
-
-
0038179347
-
Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study
-
12789222
-
Verlato G, Corsico A, Villani S, Cerveri I, Migliore E, Accordini S, et al. Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study. J Allergy Clin Immunol. 2003;111:1232-8.
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 1232-1238
-
-
Verlato, G.1
Corsico, A.2
Villani, S.3
Cerveri, I.4
Migliore, E.5
Accordini, S.6
Carolei, A.7
Piccioni, P.8
Bugiani, M.9
Lo Cascio, V.10
-
48
-
-
0032565364
-
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Beasley R and the International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee
-
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Beasley R and the International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225-1232.
-
(1998)
Lancet
, vol.351
, pp. 1225-1232
-
-
-
49
-
-
0343842958
-
IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team
-
1:STN:280:DyaK2s7hs1ShsA%3D%3D 8957114
-
Wuthrich B, Schindler C, Medici TC, Zellweger JP, Leuenberger P. IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team. Int Arch Allergy Immunol. 1996;111:396-402.
-
(1996)
Int Arch Allergy Immunol
, vol.111
, pp. 396-402
-
-
Wuthrich, B.1
Schindler, C.2
Medici, T.C.3
Zellweger, J.P.4
Leuenberger, P.5
-
50
-
-
0031736285
-
Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper
-
1:CAS:528:DyaK1cXntlWlsLg%3D 9802362
-
Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102:558-62.
-
(1998)
J Allergy Clin Immunol
, vol.102
, pp. 558-562
-
-
Bousquet, J.1
Lockey, R.2
Malling, H.J.3
-
51
-
-
0034775385
-
ARIA": global guidelines and new forms of allergen immunotherapy
-
1:STN:280:DC%2BD3Mrktlynsg%3D%3D 11590370
-
Lockey RF. "ARIA": global guidelines and new forms of allergen immunotherapy. J Allergy Clin Immunol. 2001;108:497-9.
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 497-499
-
-
Lockey, R.F.1
-
52
-
-
0025979907
-
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs
-
1668945 1:STN:280:DyaK3M7lt1egsw%3D%3D 1998791
-
Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ. 1991;302:265-9.
-
(1991)
BMJ
, vol.302
, pp. 265-269
-
-
Varney, V.A.1
Gaga, M.2
Frew, A.J.3
Aber, V.R.4
Kay, A.B.5
Durham, S.R.6
-
53
-
-
0033549827
-
Long-term clinical efficacy of grass-pollen immunotherapy
-
1:STN:280:DyaK1MzltlGjsA%3D%3D 10441602
-
Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468-75.
-
(1999)
N Engl J Med
, vol.341
, pp. 468-475
-
-
Durham, S.R.1
Walker, S.M.2
Varga, E.M.3
Jacobson, M.R.4
O'Brien, F.5
Noble, W.6
Till, S.J.7
Hamid, Q.A.8
Nouri-Aria, K.T.9
-
54
-
-
0030058309
-
Discontinuing venom immunotherapy: outcome after five years
-
1:CAS:528:DyaK28XhslOltb0%3D 8621842
-
Golden DB, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy: outcome after five years. J Allergy Clin Immunol. 1996;97:579-87.
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 579-587
-
-
Golden, D.B.1
Kwiterovich, K.A.2
Kagey-Sobotka, A.3
Valentine, M.D.4
Lichtenstein, L.M.5
-
55
-
-
0034847103
-
Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study
-
1:CAS:528:DC%2BD3MXntFKitbs%3D 11591189
-
Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001;31:1392-7.
-
(2001)
Clin Exp Allergy
, vol.31
, pp. 1392-1397
-
-
Pajno, G.B.1
Barberio, G.2
De Luca, F.3
Morabito, L.4
Parmiani, S.5
-
56
-
-
0036170801
-
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)
-
11842293
-
Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109:251-6.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 251-256
-
-
Moller, C.1
Dreborg, S.2
Ferdousi, H.A.3
Halken, S.4
Host, A.5
Jacobsen, L.6
Koivikko, A.7
Koller, D.Y.8
Niggemann, B.9
Norberg, L.A.10
-
58
-
-
0025203292
-
The Hymenoptera venom study. III: Safety of venom immunotherapy
-
1:STN:280:DyaK3M%2Fjs1Gquw%3D%3D 2229842
-
Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, Bukantz SC. The Hymenoptera venom study. III: Safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86:775-80.
-
(1990)
J Allergy Clin Immunol
, vol.86
, pp. 775-780
-
-
Lockey, R.F.1
Turkeltaub, P.C.2
Olive, E.S.3
Hubbard, J.M.4
Baird-Warren, I.A.5
Bukantz, S.C.6
-
59
-
-
0026779263
-
Systemic reactions from allergen immunotherapy
-
1401640
-
Stewart 2nd GE, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol. 1992;90:567-78.
-
(1992)
J Allergy Clin Immunol
, vol.90
, pp. 567-578
-
-
Stewart, G.E.1
Lockey, R.F.2
-
61
-
-
3042840183
-
Immunotherapy: 1999-2004
-
1:CAS:528:DC%2BD2cXltVOit7o%3D 15208577 quiz 1024
-
Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol. 2004;113:1013-23. quiz 1024.
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 1013-1023
-
-
Norman, P.S.1
-
62
-
-
3042833189
-
Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model
-
1:CAS:528:DC%2BD2cXltVOitb0%3D 15208606
-
Vissers JL, van Esch BC, Hofman GA, Kapsenberg ML, Weller FR, van Oosterhout AJ. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J Allergy Clin Immunol. 2004;113:1204-10.
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 1204-1210
-
-
Vissers, J.L.1
Van Esch, B.C.2
Hofman, G.A.3
Kapsenberg, M.L.4
Weller, F.R.5
Van Oosterhout, A.J.6
-
63
-
-
0034058399
-
Altered allergen binding capacities of Amb a 1-specific IgE and IgG4 from ragweed-sensitive patients receiving immunotherapy
-
1:CAS:528:DC%2BD3cXisFSksL0%3D 10719782
-
Pierson-Mullany LK, Jackola D, Blumenthal M, Rosenberg A. Altered allergen binding capacities of Amb a 1-specific IgE and IgG4 from ragweed-sensitive patients receiving immunotherapy. Ann Allergy Asthma Immunol. 2000;84:241-3.
-
(2000)
Ann Allergy Asthma Immunol
, vol.84
, pp. 241-243
-
-
Pierson-Mullany, L.K.1
Jackola, D.2
Blumenthal, M.3
Rosenberg, A.4
-
64
-
-
56649120612
-
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial
-
2582048 1:CAS:528:DC%2BD1cXhsVCrt7zP 19001265
-
Senti G, Prinz Vavricka BM, Erdmann I, Diaz MI, Markus R, McCormack SJ, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A. 2008;105:17908-12.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 17908-17912
-
-
Senti, G.1
Prinz Vavricka, B.M.2
Erdmann, I.3
Diaz, M.I.4
Markus, R.5
McCormack, S.J.6
Simard, J.J.7
Wuthrich, B.8
Crameri, R.9
Graf, N.10
-
65
-
-
84873359531
-
Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis
-
1:CAS:528:DC%2BC3sXhvFWmurw%3D 23374268
-
Hylander T, Latif L, Petersson-Westin U, Cardell LO. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol. 2013;131:412-20.
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 412-420
-
-
Hylander, T.1
Latif, L.2
Petersson-Westin, U.3
Cardell, L.O.4
-
66
-
-
84887022494
-
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
-
24035151 e1245
-
Witten M, Malling HJ, Blom L, Poulsen BC, Poulsen LK. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? J Allergy Clin Immunol. 2013;132:1248-52. e1245.
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 1248-1252
-
-
Witten, M.1
Malling, H.J.2
Blom, L.3
Poulsen, B.C.4
Poulsen, L.K.5
-
67
-
-
84896708970
-
Intralymphatic immunotherapy: Time interval between injections is essential
-
24439076
-
Kundig TM, Johansen P, Bachmann MF, Cardell LO, Senti G. Intralymphatic immunotherapy: Time interval between injections is essential. J Allergy Clin Immunol. 2014;133:930-1.
-
(2014)
J Allergy Clin Immunol
, vol.133
, pp. 930-931
-
-
Kundig, T.M.1
Johansen, P.2
Bachmann, M.F.3
Cardell, L.O.4
Senti, G.5
-
68
-
-
84902071102
-
Vaccine Immunology
-
6th Edition. Edited by Plotkin SA: Elsevier; Saunders, Philadelphia
-
Siegrist CA. Vaccine Immunology. In Vaccines, 6th Edition. Edited by Plotkin SA: Elsevier; Saunders, Philadelphia 2013: 14-32
-
(2013)
Vaccines
, pp. 14-32
-
-
Siegrist, C.A.1
-
69
-
-
84896705471
-
Intralymphatic immunotherapy: Time interval between injections is essential Reply
-
24439078
-
Malling HJ, Witten M, Poulsen LK. Intralymphatic immunotherapy: Time interval between injections is essential Reply. J Allergy Clin Immun. 2014;133:931-2.
-
(2014)
J Allergy Clin Immun
, vol.133
, pp. 931-932
-
-
Malling, H.J.1
Witten, M.2
Poulsen, L.K.3
-
70
-
-
58149136998
-
Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy
-
1:CAS:528:DC%2BD1MXitl2qurw%3D 19076537
-
Martinez-Gomez JM, Johansen P, Rose H, Steiner M, Senti G, Rhyner C, et al. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy. 2009;64:172-8.
-
(2009)
Allergy
, vol.64
, pp. 172-178
-
-
Martinez-Gomez, J.M.1
Johansen, P.2
Rose, H.3
Steiner, M.4
Senti, G.5
Rhyner, C.6
Crameri, R.7
Kundig, T.M.8
-
71
-
-
34548192269
-
Targeting the MHC II presentation pathway in allergy vaccine development
-
1:CAS:528:DC%2BD2sXhtVKmt7fE 17635159
-
Rhyner C, Kundig T, Akdis CA, Crameri R. Targeting the MHC II presentation pathway in allergy vaccine development. Biochem Soc Trans. 2007;35:833-4.
-
(2007)
Biochem Soc Trans
, vol.35
, pp. 833-834
-
-
Rhyner, C.1
Kundig, T.2
Akdis, C.A.3
Crameri, R.4
-
72
-
-
33846147671
-
Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines
-
1:CAS:528:DC%2BD2sXjtFCmtLk%3D 17298430
-
Crameri R, Fluckiger S, Daigle I, Kundig T, Rhyner C. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines. Allergy. 2007;62:197-206.
-
(2007)
Allergy
, vol.62
, pp. 197-206
-
-
Crameri, R.1
Fluckiger, S.2
Daigle, I.3
Kundig, T.4
Rhyner, C.5
-
73
-
-
84860486360
-
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
-
Senti G, Crameri R, Kuster D, Johansen P, Martinez-Gomez JM, Graf N, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol. 2012;129:1290-6.
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 1290-1296
-
-
Senti, G.1
Crameri, R.2
Kuster, D.3
Johansen, P.4
Martinez-Gomez, J.M.5
Graf, N.6
|